European Union regulators are expected to approve Abbott Laboratories (ABT) $33 billion acquisition of St. Jude Medical (STJ) , according to a Reuters report.
The commission is due to make a decision by Nov. 23. Neither company could be reached for comment Wednesday morning.
Both saw shares spike about 1.5% Tuesday, with Abbott hitting $39.81 per share and St. Jude reaching $79.75 per share.
